Cargando…
Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
Autores principales: | Tariq, Javeria, Gupta, Latika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190165/ https://www.ncbi.nlm.nih.gov/pubmed/34110465 http://dx.doi.org/10.1007/s00296-021-04918-z |
Ejemplares similares
-
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases
por: Raza, Hussain Ahmed, et al.
Publicado: (2021) -
COVID-19 and fertility—at the crossroads of autoimmunity and thrombosis
por: Tariq, Javeria, et al.
Publicado: (2021) -
Clinical and immunological characteristics of vaccinated patients with COVID-19
por: Ping, Yu, et al.
Publicado: (2022) -
Outcomes of Critically Ill Pregnant Women with COVID-19 in the United States
por: Easter, Sarah Rae, et al.
Publicado: (2021) -
Perinatal outcomes of pregnant women with COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)